Diasonics brings System Five to U.S.

Article

Diasonics and its European subsidiary Vingmed Sound have brought their jointly developed System Five echocardiography scanner to the North American market, debuting the scanner at last week's American Society of Echocardiography meeting. System Five

Diasonics and its European subsidiary Vingmed Sound have brought their jointly developed System Five echocardiography scanner to the North American market, debuting the scanner at last week's American Society of Echocardiography meeting. System Five becomes the vendors' premium echocardiography offering in North America, and a radiology version of the scanner is likely to follow. Diasonics/Vingmed displayed the scanner at the European Congress of Radiology in March (SCAN 3/19/97).

Diasonics and Vingmed say the new scanner represents a leap forward for the company in the use of digital technology. It's based on totally digital architecture, with a new digital beamformer. Previously, Diasonics scanners used digital technology only on their back ends. System Five also employs application-specific integrated circuits (ASICs), and Diasonics refers to the scanner as an ultrasound computer, due to its programmable design.

System Five is programmed to run 256 channels with phased-array probe technology, using acquisition speeds greater than 350 fps, according to the company. The scanner also provides 130 dB dynamic range and can be reconfigured to support more than 1000 channels, although the company did not say if that capability is currently available on the system.

In the future, the all-digital architecture of System Five will allow for the addition of capabilities such as tissue-velocity imaging, second-harmonic imaging, and 3-D imaging, according to the Santa Clara, CA-based vendor. Diasonics hopes that U.S. sales of the scanner can match the success it has achieved in Europe, where Vingmed has sold 170 systems.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.